A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancerRicardo Hitt, Javier García, E. Verger et al.|Annals of Oncology|2013Cited by 351
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric studyEduardo Díaz‐Rubio, M. Homerin, Javier Sastre et al.|Annals of Oncology|1998Cited by 228
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)Enrique Grande, Rocio García‐Carbonero, Jaume Capdevila et al.|Annals of Oncology|2015Cited by 157
Neuroendocrine neoplasms in rare locations: Clinicopathological features and review of the literatureCristina Díaz del Arco, Javier Sastre, Paloma Peinado et al.|Indian Journal of Endocrinology and Metabolism|2018Cited by 13
Activity of aflibercept (Afli) in combination with FOLFIRI (F) for patients with metastatic colorectal cancer (mCRC) in a real-life setting in Spain: Final results of the retrospective study Named Patient Program.Javier Sastre, Isabela Díaz de Corcuera Frutos, Jaime Feliú et al.|Journal of Clinical Oncology|2016Cited by 0